In conclusion, both the protective effects of multiple APOA-I genetic variants and damaging effects of APOB genetic variations impact the biomarkers of OSA patients.Obviously, the different cumulative effects of genes increase the complexity of metabolic disorders in OSA. The gene discussed is APOA1; the disease is metabolic disease.